About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Nature Cancer
›
top-articles
Nature Cancer
13.1
(top 1%)
impact factor
430
(top 50%)
papers
14.8K
(top 20%)
citations
66
(top 10%)
h
-index
13.4
(top 1%)
impact factor
751
all documents
19.1K
doc citations
100
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Nature Cancer
2020
430
2
The impact of the COVID-19 pandemic on cancer care
Nature Cancer
2020
392
3
Pan-cancer image-based detection of clinically actionable genetic alterations
Nature Cancer
2020
343
4
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis
Nature Cancer
2020
339
5
Circulating tumor DNA and liquid biopsy in oncology
Nature Cancer
2020
309
6
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Nature Cancer
2020
253
7
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
Nature Cancer
2020
240
8
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
Nature Cancer
2020
234
9
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
Nature Cancer
2020
218
10
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
Nature Cancer
2020
209
11
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Nature Cancer
2020
209
12
Cancer vaccines: the next immunotherapy frontier
Nature Cancer
2022
207
13
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
Nature Cancer
2020
201
14
Overcoming therapy resistance in EGFR-mutant lung cancer
Nature Cancer
2021
198
15
Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity
Nature Cancer
2020
178
16
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
Nature Cancer
2021
173
17
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
Nature Cancer
2021
168
18
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
Nature Cancer
2020
166
19
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
Nature Cancer
2021
163
20
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
Nature Cancer
2020
159
21
Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer
Nature Cancer
2022
150
22
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Nature Cancer
2021
147
23
Fatty acid synthesis is required for breast cancer brain metastasis
Nature Cancer
2021
147
24
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Nature Cancer
2021
147
25
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
Nature Cancer
2020
141
26
Cancer-associated fibroblasts in the single-cell era
Nature Cancer
2022
141
27
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
Nature Cancer
2020
140
28
The metabolic landscape of RAS-driven cancers from biology to therapy
Nature Cancer
2021
139
29
Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy
Nature Cancer
2020
138
30
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
Nature Cancer
2020
137
31
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer
Nature Cancer
2020
137
32
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Nature Cancer
2022
133
33
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
Nature Cancer
2020
132
34
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Nature Cancer
2021
126
35
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Nature Cancer
2022
126
36
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Nature Cancer
2020
124
37
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Nature Cancer
2021
123
38
Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology
Nature Cancer
2022
119
39
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Nature Cancer
2021
118
40
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Nature Cancer
2022
115
41
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
Nature Cancer
2020
114
42
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
Nature Cancer
2020
113
43
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial
Nature Cancer
2021
112
44
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Nature Cancer
2021
110
45
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
Nature Cancer
2022
110
46
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia
Nature Cancer
2020
108
47
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity
Nature Cancer
2020
103
48
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
Nature Cancer
2020
103
49
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
Nature Cancer
2021
102
50
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
Nature Cancer
2021
99
site/software ©
exaly
; All materials licenced under
CC by-SA
.